Atai life sciences reports fourth quarter and full year 2022 financial results and provides clinical pipeline highlights

New york and berlin, march 24, 2023 (globe newswire) -- atai life sciences (nasdaq: atai) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, reported fourth quarter and full year 2022 financial results and provided clinical pipeline highlights.
ATAI Ratings Summary
ATAI Quant Ranking